Created by potrace 1.16, written by Peter Selinger 2001-2019beatandraise.com

BRISTOL MYERS SQUIBB CO

Statements

Exhibits

d10k.htmdex3b.htmdex10aa.htmdex10cc.htmdex10dd.htmdex10ee.htmdex10mm.htmdex12.htmdex21.htmdex23.htmdex31a.htmdex31b.htmdex32a.htmdex32b.htmbmy-20101231.xmlR19.xmlR143.xmlR131.xmlR44.xmlR154.xmlR80.xmlR97.xmlR35.xmlR106.xmlR146.xmlR153.xmlR120.xmlR112.xmlR51.xmlR116.xmlR29.xmlR11.xmlR10.xmlR158.xmlR109.xmlR60.xmlR30.xmlR100.xmlR139.xmlR54.xmlR8.xmlR36.xmlR41.xmlR79.xmlR66.xmlR72.xmlR58.xmlR156.xmlR22.xmlR150.xmlR89.xmlR74.xmlR31.xmlR45.xmlR133.xmlR138.xmlR43.xmlR73.xmlR124.xmlR49.xmlR105.xmlR147.xmlR53.xmlR92.xmlR18.xmlR107.xmlR86.xmlR98.xmlR123.xmlR94.xmlR151.xmlR32.xmlR108.xmlR82.xmlR67.xmlR57.xmlR12.xmlR3.xmlR113.xmlR142.xmlR134.xmlR14.xmlR125.xmlR90.xmlR48.xmlR78.xmlR15.xmlR24.xmlR148.xmlR69.xmlR119.xmlR20.xmlR136.xmlR4.xmlR114.xmlR83.xmlR77.xmlR27.xmlR101.xmlR39.xmlR127.xmlR75.xmlR128.xmlR81.xmlR96.xmlR68.xmlR118.xmlR135.xmlR70.xmlR50.xmlR33.xmlR16.xmlR28.xmlR102.xmlR76.xmlR52.xmlR62.xmlR122.xmlR130.xmlR9.xmlR6.xmlR61.xmlR88.xmlR152.xmlR91.xmlR85.xmlR5.xmlR23.xmlR115.xmldefnref.xmlR95.xmlR84.xmlR155.xmlR121.xmlR46.xmlR21.xmlR99.xmlR87.xmlR13.xmlR34.xmlR26.xmlR93.xmlR59.xmlR129.xmlR64.xmlR1.xmlR2.xmlR132.xmlR103.xmlR37.xmlR63.xmlR56.xmlR144.xmlR111.xmlFinancial_Report.xlsR110.xmlR55.xmlR157.xmlR47.xmlR141.xmlR38.xmlR145.xmlR25.xmlR7.xmlR117.xmlR65.xmlR137.xmlR126.xmlR149.xmlR40.xmlR71.xmlR42.xmlR17.xmlR140.xmlR104.xml

Graphics

g129099g91z29.gif
NotesSupport
aboutterms
2.2.0.25truefalse40304 - Disclosure - BUSINESS SEGMENT INFORMATION (Net Sales of Key Products) (Details)truefalseIn Millionsfalse1falsefalseUSDfalsefalse10/1/2010 - 12/31/2010 USD ($) USD ($) / shares $Duration_10_1_2010_To_12_31_2010http://www.sec.gov/CIK0000014272duration2010-10-01T00:00:002010-12-31T00:00:00Unit1Standardhttp://www.xbrl.org/2003/iso4217USDiso42170Unit12Dividehttp://www.xbrl.org/2003/iso4217USDiso4217http://www.xbrl.org/2003/instancesharesxbrli0USDUSD$2falsefalseUSDfalsefalse7/1/2010 - 9/30/2010 USD ($) USD ($) / shares $Duration_7_1_2010_To_9_30_2010http://www.sec.gov/CIK0000014272duration2010-07-01T00:00:002010-09-30T00:00:00Unit1Standardhttp://www.xbrl.org/2003/iso4217USDiso42170Unit12Dividehttp://www.xbrl.org/2003/iso4217USDiso4217http://www.xbrl.org/2003/instancesharesxbrli0USDUSD$3falsefalseUSDfalsefalse4/1/2010 - 6/30/2010 USD ($) USD ($) / shares $Duration_4_1_2010_To_6_30_2010http://www.sec.gov/CIK0000014272duration2010-04-01T00:00:002010-06-30T00:00:00Unit1Standardhttp://www.xbrl.org/2003/iso4217USDiso42170Unit12Dividehttp://www.xbrl.org/2003/iso4217USDiso4217http://www.xbrl.org/2003/instancesharesxbrli0USDUSD$4falsefalseUSDfalsefalse1/1/2010 - 3/31/2010 USD ($) / shares USD ($) $Duration_1_1_2010_To_3_31_2010http://www.sec.gov/CIK0000014272duration2010-01-01T00:00:002010-03-31T00:00:00Unit12Dividehttp://www.xbrl.org/2003/iso4217USDiso4217http://www.xbrl.org/2003/instancesharesxbrli0Unit1Standardhttp://www.xbrl.org/2003/iso4217USDiso42170USDUSD$5falsefalseUSDfalsefalse10/1/2009 - 12/31/2009 USD ($) USD ($) / shares $Duration_10_1_2009_To_12_31_2009http://www.sec.gov/CIK0000014272duration2009-10-01T00:00:002009-12-31T00:00:00Unit1Standardhttp://www.xbrl.org/2003/iso4217USDiso42170Unit12Dividehttp://www.xbrl.org/2003/iso4217USDiso4217http://www.xbrl.org/2003/instancesharesxbrli0USDUSD$6falsefalseUSDfalsefalse7/1/2009 - 9/30/2009 USD ($) USD ($) / shares $Duration_7_1_2009_To_9_30_2009http://www.sec.gov/CIK0000014272duration2009-07-01T00:00:002009-09-30T00:00:00Unit1Standardhttp://www.xbrl.org/2003/iso4217USDiso42170Unit12Dividehttp://www.xbrl.org/2003/iso4217USDiso4217http://www.xbrl.org/2003/instancesharesxbrli0USDUSD$7falsefalseUSDfalsefalse4/1/2009 - 6/30/2009 USD ($) USD ($) / shares $Duration_4_1_2009_To_6_30_2009http://www.sec.gov/CIK0000014272duration2009-04-01T00:00:002009-06-30T00:00:00Unit1Standardhttp://www.xbrl.org/2003/iso4217USDiso42170Unit12Dividehttp://www.xbrl.org/2003/iso4217USDiso4217http://www.xbrl.org/2003/instancesharesxbrli0USDUSD$8falsefalseUSDfalsefalse1/1/2009 - 3/31/2009 USD ($) USD ($) / shares $Duration_1_1_2009_To_3_31_2009http://www.sec.gov/CIK0000014272duration2009-01-01T00:00:002009-03-31T00:00:00Unit1Standardhttp://www.xbrl.org/2003/iso4217USDiso42170Unit12Dividehttp://www.xbrl.org/2003/iso4217USDiso4217http://www.xbrl.org/2003/instancesharesxbrli0USDUSD$9falsefalseUSDfalsefalse1/1/2010 - 12/31/2010 USD ($) USD ($) / shares $Duration_1_1_2010_To_12_31_2010http://www.sec.gov/CIK0000014272duration2010-01-01T00:00:002010-12-31T00:00:00Unit1Standardhttp://www.xbrl.org/2003/iso4217USDiso42170Unit13Standardhttp://www.xbrl.org/2003/instancepurexbrli0Unit12Divide< MeasureSchema>http://www.xbrl.org/2003/iso4217USDiso4217http://www.xbrl.org/2003/instancesharesxbrli0Unit15Standardhttp://www.xbrl.org/2003/instancesharesxbrli0USDUSD$10falsefalseUSDfalsefalse1/1/2009 - 12/31/2009 USD ($) USD ($) / shares $Duration_1_1_2009_To_12_31_2009http://www.sec.gov/CIK0000014272duration2009-01-01T00:00:002009-12-31T00:00:00Unit1Standardhttp://www.xbrl.org/2003/iso4217USDiso42170Unit15Standardhttp://www.xbrl.org/2003/instancesharesxbrli0Unit12Dividehttp://www.xbrl.org/2003/iso4217USDiso4217http://www.xbrl.org/2003/instancesharesxbrli0Unit13Standardhttp://www.xbrl.org/2003/instancepurexbrli0USDUSD$11falsefalseUSDfalsefalse1/1/2008 - 12/31/2008 USD ($) USD ($) / shares $Duration_1_1_2008_To_12_31_20083http://www.sec.gov/CIK0000014272duration2008-01-01T00:00:002008-12-31T00:00:00Unit1Standardhttp://www.xbrl.org/2003/iso4217USDiso42170Unit15Standardhttp://www.xbrl.org/2003/instancesharesxbrli0Unit13Standardhttp://www.xbrl.org/2003/instancepurexbrli0Unit12Dividehttp://www.xbrl.org/2003/iso4217USDiso4217http://www.xbrl.org/2003/instancesharesxbrli0USDUSD$2false0us-gaap_SalesRevenueNetus-gaaptruecreditdurationNo definition available.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:monetaryItemTypemonetaryTotal revenue from sale of goods and services rendered during the reporting period, in the normal course of business, reduced by sales returns and allowances, and sales discounts.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Section 03 -Paragraph 1 -Article 5 falsefalse3false0natruenanaNo definition available.falsetruefalsefalsefalsefalsefalsefalsefalsefalsehttp://www.bms.com/taxonomy/role/disclosurebusinesssegmentinformationnetsalesofkeyproductsdetails1falsefals efalse00falsefalsefalsefalsefalse2falsefalsefalse00falsefalsefalsefalsefalse3falsefalsefalse00falsefalsefalsefalsefalse4falsefalsefalse00falsefalsefalsefalsefalse5falsefalsefalse00falsefalsefalsefalsefalse6falsefalsefalse00falsefalsefalsefalsefalse7falsefalsefalse00falsefalsefalsefalsefalse8falsefalsefalse00falsefalsefalsefalsefalse9falsefalsefalse00falsefalsefalsefalsefalse10falsefalsefalse00falsefalsefalsefalsefalse11falsefalsefalse00falsefalsefalsefalsefalse12falsefalseUSDtruefalse{us-gaap_ConcentrationRiskByBenchmarkAxis} : Sales Revenue Segment Plavix [Member] 1/1/2010 - 12/31/2010 USD ($) $Duration_1_1_2010_To_12_31_201022121http://www.sec.gov/CIK0000014272duration2010-01-01T00:00:002010-12-31T00:00:00falsefalseSales Revenue Segment Plavix [Member]us-gaap_ConcentrationRiskByBenchmarkAxisxbrldihttp://xbrl.org/2006/xbrldibmy_SalesRevenueSegmentPlavixMemberus-gaap_ConcentrationRiskByBenchmarkAxisexplicitMemberUnit1Standardhttp://www.x brl.org/2003/iso4217USDiso42170USDUSD$13falsefalseUSDtruefalse{us-gaap_ConcentrationRiskByBenchmarkAxis} : Sales Revenue Segment Plavix [Member] 1/1/2009 - 12/31/2009 USD ($) $Duration_1_1_2009_To_12_31_200922106http://www.sec.gov/CIK0000014272duration2009-01-01T00:00:002009-12-31T00:00:00falsefalseSales Revenue Segment Plavix [Member]us-gaap_ConcentrationRiskByBenchmarkAxisxbrldihttp://xbrl.org/2006/xbrldibmy_SalesRevenueSegmentPlavixMemberus-gaap_ConcentrationRiskByBenchmarkAxisexplicitMemberUnit1Standardhttp://www.x brl.org/2003/iso4217USDiso42170USDUSD$14falsefalseUSDtruefalse{us-gaap_ConcentrationRiskByBenchmarkAxis} : Sales Revenue Segment Plavix [Member] 1/1/2008 - 12/31/2008 USD ($) $Duration_1_1_2008_To_12_31_20083234http://www.sec.gov/CIK0000014272duration2008-01-01T00:00:002008-12-31T00:00:00falsefalseSales Revenue Segment Plavix [Member]us-gaap_ConcentrationRiskByBenchmarkAxisxbrldihttp://xbrl.org/2006/xbrldibmy_SalesRevenueSegmentPlavixMemberus-gaap_ConcentrationRiskByBenchmarkAxisexplicitMemberUnit1Standardhttp://www.xb rl.org/2003/iso4217USDiso42170USDUSD$OthernaNo definition available.No authoritative reference available.falsefalse4false0us-gaap_SalesRevenueNetus-gaaptruecreditdurationNo definition available.falsefalsefalsefalsefalsefalsefalsefalsefalsefalseterselabel1falsefalsefalse00falsefalsefalsefalsefalse2falsefalsefalse00falsefalsefalsefalsefalse3falsefalsefalse00falsefalsefalse falsefalse4falsefalsefalse00falsefalsefalsefalsefalse5falsefalsefalse00falsefalsefalsefalse false6falsefalsefalse00falsefalsefalsefalsefalse7falsefalsefalse00falsefalsefalsefalsefalse8falsefalsefalse00falsefalsefalsefalsefalse9truefalsefalse66660000006666falsefalsefalsefals efalse10truefalsefalse61460000006146falsefalsefalsefalsefalse11truefalsefalse56030000005603falsefalsefalsefalsefalseMonetaryxbrli:monetaryItemTypemonetaryTotal revenue from sale of goods and services rendered during the reporting period, in the normal course of business, reduced by sales returns and allowances, and sales discounts.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Section 03 -Paragraph 1 -Article 5 falsefalse5false0natruenanaNo definition available.falsetruefalsefalsefalsefalsefalsefalsefalsefalsehttp://www.bms.com/taxonomy/role/disclosurebusinesssegmentinformationnetsalesofkeyproductsdetails1falsefals efalse00falsefalsefalsefalsefalse2falsefalsefalse00falsefalsefalsefalsefalse3falsefalsefalse00falsefalsefalsefalsefalse4falsefalsefalse00falsefalsefalsefalsefalse5falsefalsefalse00falsefalsefalsefalsefalse6falsefalsefalse00falsefalsefalsefalsefalse7falsefalsefalse00falsefalsefalsefalsefalse8falsefalsefalse00falsefalsefalsefalsefalse9falsefalsefalse00falsefalsefalsefalsefalse10falsefalsefalse00falsefalsefalsefalsefalse11falsefalsefalse00falsefalsefalsefalsefalse15falsefalseUSDtruefalse{us-gaap_ConcentrationRiskByBenchmarkAxis} : Sales Revenue Segment Avapro/Avalide [Member] 1/1/2010 - 12/31/2010 USD ($) $Duration_1_1_2010_To_12_31_2010826http://www.sec.gov/CIK0000014272duration2010-01-01T00:00:002010-12-31T00:00:00falsefalseSales Revenue Segment Avapro/Avalide [Member]us-gaap_ConcentrationRiskByBenchmarkAxisxbrldihttp://xbrl.org/2006/xbrldibmy_SalesRevenueSegmentAvaproAvalideMemberus-gaap_ConcentrationRiskByBenchmarkAxisexplicitMemberUnit1Standardhttp://www.xbrl.org/2003/iso4217USDiso42170USDUSD$16falsefalseUSDtruefalse{us-gaap_ConcentrationRiskByBenchmarkAxis} : Sales Revenue Segment Avapro/Avalide [Member] 1/1/2009 - 12/31/2009 USD ($) $Duration_1_1_2009_To_12_31_20092299http://www.sec.gov/CIK0000014272duration2009-01-01T00:00:002009-12-31T00:00:00falsefalseSales Revenue Segment Avapro/Avalide [Member]us-gaap_ConcentrationRiskByBenchmarkAxisxbrldihttp://xbrl.org/2006/xbrldibmy_SalesRevenueSegmentAvaproAvalideMemberus-gaap_ConcentrationRiskByBenchmarkAxisexplicitMemberUnit1Standardhttp://www.xbrl.org/2003/iso4217USDiso42170USDUSD$17falsefalseUSDtruefalse{us-gaap_ConcentrationRiskByBenchmarkAxis} : Sales Revenue Segment Avapro/Avalide [Member] 1/1/2008 - 12/31/2008 USD ($) $Duration_1_1_2008_To_12_31_20083227http://www.sec.gov/CIK0000014272duration2008-01-01T00:00:002008-12-31T00:00:00falsefalseSales Revenue Segment Avapro/Avalide [Member]us-gaap_ConcentrationRiskByBenchmarkAxisxbrldihttp://xbrl.org/2006/xbrldibmy_SalesRevenueSegmentAvaproAvalideMemberus-gaap_ConcentrationRiskByBenchmarkAxisexplicitMemberUnit1Standardhttp://www.xbrl.org/2003/iso4217USDiso42170USDUSD$OthernaNo definition available.No authoritative reference available.falsefalse6false0us-gaap_SalesRevenueNetus-gaaptruecreditdurationNo definition available.falsefalsefalsefalsefalsefalsefalsefalsefalsefalseterselabel1falsefalsefalse00falsefalsefalse< /DisplayDateInUSFormat>falsefalse2falsefalsefalse00falsefalsefalsefalsefalse3falsefalsefalse00falsefalsefalsefalsefalse4falsefalsefalse00falsefalsefalsefalsefalse5falsefalsefalse00falsefalsefalsefalsefalse6falsefalsefalse00falsefalsefalsefalsefalse7falsefalsefalse00falsefalsefalsefalsefalse8falsefalsefalse00falsefalsefalsefalsefalse9truefalsefalse11760000001176falsefalsefalsefalsefalse10truefalsefalse12830000001283falsefalsefalsefalsefalse11truefalsefalse12900000001290falsefalsefalsefalsefalseMonetaryxbrli:monetaryItemTypemonetaryTotal revenue from sale of goods and services rendered during the reporting period, in the normal course of business, reduced by sales returns and allowances, and sales discounts.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Section 03 -Paragraph 1 -Article 5 falsefalse7false0natruenanaNo definition available.falsetruefalsefalsefalsefalsefalsefalsefalsefalsehttp://www.bms.com/taxonomy/role/disclosurebusinesssegmentinformationnetsalesofkeyproductsdetails1falsefals efalse00falsefalsefalsefalsefalse2falsefalsefalse00falsefalsefalsefalsefalse3falsefalsefalse00falsefalsefalsefalsefalse4falsefalsefalse00falsefalsefalsefalsefalse5falsefalsefalse00falsefalsefalsefalsefalse6falsefalsefalse00falsefalsefalsefalsefalse7falsefalsefalse00falsefalsefalsefalsefalse8falsefalsefalse00falsefalsefalsefalsefalse9falsefalsefalse00falsefalsefalsefalsefalse10falsefalsefalse00falsefalsefalsefalsefalse11falsefalsefalse00falsefalsefalsefalsefalse18falsefalseUSDtruefalse{us-gaap_ConcentrationRiskByBenchmarkAxis} : Sales Revenue Segment Abilify [Member] 1/1/2010 - 12/31/2010 USD ($) $Duration_1_1_2010_To_12_31_2010746http://www.sec.gov/CIK0000014272duration2010-01-01T00:00:002010-12-31T00:00:00falsefalseSales Revenue Segment Abilify [Member]us-gaap_ConcentrationRiskByBenchmarkAxisxbrldihttp://xbrl.org/2006/xbrldibmy_SalesRevenueSegmentAbilifyMemberus-gaap_ConcentrationRiskByBenchmarkAxisexplicitMemberUnit1Standardhttp://www.x brl.org/2003/iso4217USDiso42170USDUSD$19falsefalseUSDtruefalse{us-gaap_ConcentrationRiskByBenchmarkAxis} : Sales Revenue Segment Abilify [Member] 1/1/2009 - 12/31/2009 USD ($) $Duration_1_1_2009_To_12_31_20092298http://www.sec.gov/CIK0000014272duration2009-01-01T00:00:002009-12-31T00:00:00falsefalseSales Revenue Segment Abilify [Member]us-gaap_ConcentrationRiskByBenchmarkAxisxbrldihttp://xbrl.org/2006/xbrldibmy_SalesRevenueSegmentAbilifyMemberus-gaap_ConcentrationRiskByBenchmarkAxisexplicitMemberUnit1Standardhttp://www. xbrl.org/2003/iso4217USDiso42170USDUSD$20falsefalseUSDtruefalse{us-gaap_ConcentrationRiskByBenchmarkAxis} : Sales Revenue Segment Abilify [Member] 1/1/2008 - 12/31/2008 USD ($) $Duration_1_1_2008_To_12_31_20083226http://www.sec.gov/CIK0000014272duration2008-01-01T00:00:002008-12-31T00:00:00falsefalseSales Revenue Segment Abilify [Member]us-gaap_ConcentrationRiskByBenchmarkAxisxbrldihttp://xbrl.org/2006/xbrldibmy_SalesRevenueSegmentAbilifyMemberus-gaap_ConcentrationRiskByBenchmarkAxisexplicitMemberUnit1Standardhttp://www. xbrl.org/2003/iso4217USDiso42170USDUSD$OthernaNo definition available.No authoritative reference available.falsefalse8false0us-gaap_SalesRevenueNetus-gaaptruecreditdurationNo definition available.falsefalsefalsefalsefalsefalsefalsefalsefalsefalseterselabel1falsefalsefalse00falsefalsefalsefalsefalse2falsefalsefalse00falsefalsefalsefalsefalse3falsefalsefalse00falsefalsefalsefalsefalse4falsefalsefalse00falsefalsefalsefalsefalse5falsefalsefalse00falsefalsefalsef alsefalse6falsefalsefalse00falsefalsefalsefalsefalse7falsefalsefalse00falsefalsefalsefalse< /hasSegments>false8falsefalsefalse00falsefalsefalsefalsefalse9truefalsefalse25650000002565falsefalsefalse falsefalse10truefalsefalse25920000002592falsefalsefalsefalsefalse11truefalsefalse21530000002153falsefalsefalsefalsefalseMonetaryxbrli:monetaryItemTypemonetaryTotal revenue from sale of goods and services rendered during the reporting period, in the normal course of business, reduced by sales returns and allowances, and sales discounts.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Section 03 -Paragraph 1 -Article 5 falsefalse9false0natruenanaNo definition available.falsetruefalsefalsefalsefalsefalsefalsefalsefalsehttp://www.bms.com/taxonomy/role/disclosurebusinesssegmentinformationnetsalesofkeyproductsdetails1falsefals efalse00falsefalsefalsefalsefalse2falsefalsefalse00falsefalsefalsefalsefalse3falsefalsefalse00falsefalsefalsefalsefalse4falsefalsefalse00falsefalsefalsefalsefalse5falsefalsefalse00falsefalsefalsefalsefalse6falsefalsefalse00falsefalsefalsefalsefalse7falsefalsefalse00falsefalsefalsefalsefalse8falsefalsefalse00falsefalsefalsefalsefalse9falsefalsefalse00falsefalsefalsefalsefalse10falsefalsefalse00falsefalsefalsefalsefalse11falsefalsefalse00falsefalsefalsefalsefalse21falsefalseUSDtruefalse{us-gaap_ConcentrationRiskByBenchmarkAxis} : Sales Revenue Segment Reyataz [Member] 1/1/2010 - 12/31/2010 USD ($) $Duration_1_1_2010_To_12_31_201022122http://www.sec.gov/CIK0000014272duration2010-01-01T00:00:002010-12-31T00:00:00falsefalseSales Revenue Segment Reyataz [Member]us-gaap_ConcentrationRiskByBenchmarkAxisxbrldihttp://xbrl.org/2006/xbrldibmy_SalesRevenueSegmentReyatazMemberus-gaap_ConcentrationRiskByBenchmarkAxisexplicitMemberUnit1Standardhttp://www .xbrl.org/2003/iso4217USDiso42170USDUSD$22falsefalseUSDtruefalse{us-gaap_ConcentrationRiskByBenchmarkAxis} : Sales Revenue Segment Reyataz [Member] 1/1/2009 - 12/31/2009 USD ($) $Duration_1_1_2009_To_12_31_200922107http://www.sec.gov/CIK0000014272duration2009-01-01T00:00:002009-12-31T00:00:00falsefalseSales Revenue Segment Reyataz [Member]us-gaap_ConcentrationRiskByBenchmarkAxisxbrldihttp://xbrl.org/2006/xbrldibmy_SalesRevenueSegmentReyatazMemberus-gaap_ConcentrationRiskByBenchmarkAxisexplicitMemberUnit1Standardhttp://www .xbrl.org/2003/iso4217USDiso42170USDUSD$23falsefalseUSDtruefalse{us-gaap_ConcentrationRiskByBenchmarkAxis} : Sales Revenue Segment Reyataz [Member] 1/1/2008 - 12/31/2008 USD ($) $Duration_1_1_2008_To_12_31_20083235http://www.sec.gov/CIK0000014272duration2008-01-01T00:00:002008-12-31T00:00:00falsefalseSales Revenue Segment Reyataz [Member]us-gaap_ConcentrationRiskByBenchmarkAxisxbrldihttp://xbrl.org/2006/xbrldibmy_SalesRevenueSegmentReyatazMemberus-gaap_ConcentrationRiskByBenchmarkAxisexplicitMemberUnit1Standardhttp://www. xbrl.org/2003/iso4217USDiso42170USDUSD$OthernaNo definition available.No authoritative reference available.falsefalse10false0us-gaap_SalesRevenueNetus-gaaptruecreditdurationNo definition available.falsefalsefalsefalsefalsefalsefalsefalsefalsefalseterselabel1falsefalsefalse00falsefalsefalsefalsefalse2falsefalsefalse00falsefalsefalsefalsefalse3falsefalsefalse00falsefalsefalsefalsefalse4falsefalsefalse00falsefalsefalsefalsefalse5falsefalsefalse00falsefalsefalse falsefalse6falsefalsefalse00falsefalsefalsefalsefalse7falsefalsefalse00falsefalsefalsefalse false8falsefalsefalse00falsefalsefalsefalsefalse9truefalsefalse14790000001479falsefalsefalsefalsefalse10truefalsefalse14010000001401falsefalsefalsefalsefalse11truefalsefalse12920000001292falsefalsefalsefalsefalseMonetaryxbrli:monetaryItemTypemonetaryTotal revenue from sale of goods and services rendered during the reporting period, in the normal course of business, reduced by sales returns and allowances, and sales discounts.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Section 03 -Paragraph 1 -Article 5 falsefalse11false0natruenanaNo definition available.falsetruefalsefalsefalsefalsefalsefalsefalsefalsehttp://www.bms.com/taxonomy/role/disclosurebusinesssegmentinformationnetsalesofkeyproductsdetails1falsefal sefalse00falsefalsefalsefalsefalse2falsefalsefalse00falsefalsefalsefalsefalse3falsefalsefalse00falsefalsefalsefalsefalse4falsefalsefalse00falsefalsefalsefalsefalse5falsefalsefalse00falsefalsefalsefalsefalse6falsefalsefalse00falsefalsefalsefalsefalse7falsefalsefalse00falsefalsefalsefalsefalse8falsefalsefalse00falsefalsefalsefalsefalse9falsefalsefalse00falsefalsefalsefalsefalse10falsefalsefalse00falsefalsefalsefalsefalse11falsefalsefalse00falsefalsefalsefalsefalse24falsefalseUSDtruefalse{us-gaap_ConcentrationRiskByBenchmarkAxis} : Sales Revenue Segment Sustiva Franchise [Member] 1/1/2010 - 12/31/2010 USD ($) $Duration_1_1_2010_To_12_31_201022124http://www.sec.gov/CIK0000014272duration2010-01-01T00:00:002010-12-31T00:00:00falsefalseSales Revenue Segment Sustiva Franchise [Member]us-gaap_ConcentrationRiskByBenchmarkAxisxbrldihttp://xbrl.org/2006/xbrldibmy_SalesRevenueSegmentSustivaFranchiseMemberus-gaap_ConcentrationRiskByBenchmarkAxisexplicitMemberUnit1Standardhttp://www.xbrl.org/2003/iso4217USDiso42170USDUSD$25falsefalseUSDtruefalse{us-gaap_ConcentrationRiskByBenchmarkAxis} : Sales Revenue Segment Sustiva Franchise [Member] 1/1/2009 - 12/31/2009 USD ($) $Duration_1_1_2009_To_12_31_200922109http://www.sec.gov/CIK0000014272duration2009-01-01T00:00:002009-12-31T00:00:00falsefalseSales Revenue Segment Sustiva Franchise [Member]us-gaap_ConcentrationRiskByBenchmarkAxisxbrldihttp://xbrl.org/2006/xbrldibmy_SalesRevenueSegmentSustivaFranchiseMemberus-gaap_ConcentrationRiskByBenchmarkAxisexplicitMemberUnit1Standardhttp://www.xbrl.org/2003/iso4217USDiso42170USDUSD$26falsefalseUSDtruefalse{us-gaap_ConcentrationRiskByBenchmarkAxis} : Sales Revenue Segment Sustiva Franchise [Member] 1/1/2008 - 12/31/2008 USD ($) $Duration_1_1_2008_To_12_31_20083237http://www.sec.gov/CIK0000014272duration2008-01-01T00:00:002008-12-31T00:00:00falsefalseSales Revenue Segment Sustiva Franchise [Member]us-gaap_ConcentrationRiskByBenchmarkAxisxbrldihttp://xbrl.org/2006/xbrldibmy_SalesRevenueSegmentSustivaFranchiseMemberus-gaap_ConcentrationRiskByBenchmarkAxisexplicitMemberUnit1Standardhttp://www.xbrl.org/2003/iso4217USDiso42170USDUSD$OthernaNo definition available.No authoritative reference available.falsefalse12false0us-gaap_SalesRevenueNetus-gaaptruecreditdurationNo definition available.falsefalsefalsefalsefalsefalsefalsefalsefalsefalseterselabel1falsefalsefalse00falsefalsefalsefalsefalse2falsefalsefalse00falsefalsefalsefalsefalse3falsefalsefalse00falsefalsefalsefalsefalse4falsefalsefalse00falsefalsefalsefalsefalse5falsefalsefalse00falsefalsefal sefalsefalse6falsefalsefalse00falsefalsefalsefalsefalse7falsefalsefalse00falsefalsefalsefalsefalse8falsefalsefalse00falsefalsefalsefalsefalse9truefalsefalse13680000001368falsefalsefa lsefalsefalse10truefalsefalse12770000001277falsefalsefalsefalsefalse11truefalsefalse11490000001149falsefalsefalsefalsefalseMonetaryxbrli:monetaryItemTypemonetaryTotal revenue from sale of goods and services rendered during the reporting period, in the normal course of business, reduced by sales returns and allowances, and sales discounts.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Section 03 -Paragraph 1 -Article 5 falsefalse13false0natruenanaNo definition available.falsetruefalsefalsefalsefalsefalsefalsefalsefalsehttp://www.bms.com/taxonomy/role/disclosurebusinesssegmentinformationnetsalesofkeyproductsdetails1falsefal sefalse00falsefalsefalsefalsefalse2falsefalsefalse00falsefalsefalsefalsefalse3falsefalsefalse00falsefalsefalsefalsefalse4falsefalsefalse00falsefalsefalsefalsefalse5falsefalsefalse00falsefalsefalsefalsefalse6falsefalsefalse00falsefalsefalsefalsefalse7falsefalsefalse00falsefalsefalsefalsefalse8falsefalsefalse00falsefalsefalsefalsefalse9falsefalsefalse00falsefalsefalsefalsefalse10falsefalsefalse00falsefalsefalsefalsefalse11falsefalsefalse00falsefalsefalsefalsefalse27falsefalseUSDtruefalse{us-gaap_ConcentrationRiskByBenchmarkAxis} : Sales Revenue Segment Baraclude [Member] 1/1/2010 - 12/31/2010 USD ($) $Duration_1_1_2010_To_12_31_2010827http://www.sec.gov/CIK0000014272duration2010-01-01T00:00:002010-12-31T00:00:00falsefalseSales Revenue Segment Baraclude [Member]us-gaap_ConcentrationRiskByBenchmarkAxisxbrldihttp://xbrl.org/2006/xbrldibmy_SalesRevenueSegmentBaracludeMemberus-gaap_ConcentrationRiskByBenchmarkAxisexplicitMemberUnit1Standardhttp://w ww.xbrl.org/2003/iso4217USDiso42170USDUSD$28falsefalseUSDtruefalse{us-gaap_ConcentrationRiskByBenchmarkAxis} : Sales Revenue Segment Baraclude [Member] 1/1/2009 - 12/31/2009 USD ($) $Duration_1_1_2009_To_12_31_200922100http://www.sec.gov/CIK0000014272duration2009-01-01T00:00:002009-12-31T00:00:00falsefalseSales Revenue Segment Baraclude [Member]us-gaap_ConcentrationRiskByBenchmarkAxisxbrldihttp://xbrl.org/2006/xbrldibmy_SalesRevenueSegmentBaracludeMemberus-gaap_ConcentrationRiskByBenchmarkAxisexplicitMemberUnit1Standardhttp:/ /www.xbrl.org/2003/iso4217USDiso42170USDUSD$29falsefalseUSDtruefalse{us-gaap_ConcentrationRiskByBenchmarkAxis} : Sales Revenue Segment Baraclude [Member] 1/1/2008 - 12/31/2008 USD ($) $Duration_1_1_2008_To_12_31_20083228http://www.sec.gov/CIK0000014272duration2008-01-01T00:00:002008-12-31T00:00:00falsefalseSales Revenue Segment Baraclude [Member]us-gaap_ConcentrationRiskByBenchmarkAxisxbrldihttp://xbrl.org/2006/xbrldibmy_SalesRevenueSegmentBaracludeMemberus-gaap_ConcentrationRiskByBenchmarkAxisexplicitMemberUnit1Standardhttp:// www.xbrl.org/2003/iso4217USDiso42170USDUSD$OthernaNo definition available.No authoritative reference available.falsefalse14false0us-gaap_SalesRevenueNetus-gaaptruecreditdurationNo definition available.falsefalsefalsefalsefalsefalsefalsefalsefalsefalseterselabel1falsefalsefalse00falsefalsefalsefalsefalse2falsefalsefalse00falsefalsefalsefalsefalse3falsefalsefalse00falsefalsefalse falsefalse4falsefalsefalse00falsefalsefalsefalsefalse5falsefalsefalse00falsefalsefalsefalsefalse6falsefalsefalse00falsefalsefalsefalsefalse7falsefalsefalse00falsefalsefalsefalsefalse8falsefalsefalse00falsefalsefalsefalsefalse9truefalsefalse931000000931falsefalsefalsefalsefalse10truefalsefalse734000000734falsefalsefalsefalsefalse11truefalsefalse541000000541falsefalsefalsefalsefalseMonetaryxbrli:monetaryItemTypemonetaryTotal revenue from sale of goods and services rendered during the reporting period, in the normal course of business, reduced by sales returns and allowances, and sales discounts.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Section 03 -Paragraph 1 -Article 5 falsefalse15false0natruenanaNo definition available.falsetruefalsefalsefalsefalsefalsefalsefalsefalsehttp://www.bms.com/taxonomy/role/disclosurebusinesssegmentinformationnetsalesofkeyproductsdetails1falsefal sefalse00falsefalsefalsefalsefalse2falsefalsefalse00falsefalsefalsefalsefalse3falsefalsefalse00falsefalsefalsefalsefalse4falsefalsefalse00falsefalsefalsefalsefalse5falsefalsefalse00falsefalsefalsefalsefalse6falsefalsefalse00falsefalsefalsefalsefalse7falsefalsefalse00falsefalsefalsefalsefalse8falsefalsefalse00falsefalsefalsefalsefalse9falsefalsefalse00falsefalsefalsefalsefalse10falsefalsefalse00falsefalsefalsefalsefalse11falsefalsefalse00falsefalsefalsefalsefalse30falsefalseUSDtruefalse{us-gaap_ConcentrationRiskByBenchmarkAxis} : Sales Revenue Segment Erbitux [Member] 1/1/2010 - 12/31/2010 USD ($) $Duration_1_1_2010_To_12_31_201096http://www.sec.gov/CIK0000014272duration2010-01-01T00:00:002010-12-31T00:00:00falsefalseSales Revenue Segment Erbitux [Member]us-gaap_ConcentrationRiskByBenchmarkAxisxbrldihttp://xbrl.org/2006/xbrldibmy_SalesRevenueSegmentErbituxMemberus-gaap_ConcentrationRiskByBenchmarkAxisexplicitMemberUnit1Standardhttp://www.xb rl.org/2003/iso4217USDiso42170USDUSD$31falsefalseUSDtruefalse{us-gaap_ConcentrationRiskByBenchmarkAxis} : Sales Revenue Segment Erbitux [Member] 1/1/2009 - 12/31/2009 USD ($) $Duration_1_1_2009_To_12_31_200922101http://www.sec.gov/CIK0000014272duration2009-01-01T00:00:002009-12-31T00:00:00falsefalseSales Revenue Segment Erbitux [Member]us-gaap_ConcentrationRiskByBenchmarkAxisxbrldihttp://xbrl.org/2006/xbrldibmy_SalesRevenueSegmentErbituxMemberus-gaap_ConcentrationRiskByBenchmarkAxisexplicitMemberUnit1Standardhttp://www .xbrl.org/2003/iso4217USDiso42170USDUSD$32falsefalseUSDtruefalse{us-gaap_ConcentrationRiskByBenchmarkAxis} : Sales Revenue Segment Erbitux [Member] 1/1/2008 - 12/31/2008 USD ($) $Duration_1_1_2008_To_12_31_20083229http://www.sec.gov/CIK0000014272duration2008-01-01T00:00:002008-12-31T00:00:00falsefalseSales Revenue Segment Erbitux [Member]us-gaap_ConcentrationRiskByBenchmarkAxisxbrldihttp://xbrl.org/2006/xbrldibmy_SalesRevenueSegmentErbituxMemberus-gaap_ConcentrationRiskByBenchmarkAxisexplicitMemberUnit1Standardhttp://www. xbrl.org/2003/iso4217USDiso42170USDUSD$OthernaNo definition available.No authoritative reference available.falsefalse16false0us-gaap_SalesRevenueNetus-gaaptruecreditdurationNo definition available.falsefalsefalsefalsefalsefalsefalsefalsefalsefalseterselabel1falsefalsefalse00falsefalsefalsefalsefalse2falsefalsefalse00falsefalsefalsefalsefalse3falsefalsefalse00falsefalsefalsefalsefalse4falsefalsefalse00falsefalsefalsefalsefalse5falsefalsefalse00falsefalsefalse falsefalse6falsefalsefalse00falsefalsefalsefalsefalse7falsefalsefalse00falsefalsefalsefalse false8falsefalsefalse00falsefalsefalsefalsefalse9truefalsefalse662000000662falsefalsefalsef alsefalse10truefalsefalse683000000683falsefalsefalsefalsefalse11truefalsefalse749000000749falsefalsefalsefalsefalseMonetaryxbrli:monetaryItemTypemonetaryTotal revenue from sale of goods and services rendered during the reporting period, in the normal course of business, reduced by sales returns and allowances, and sales discounts.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Section 03 -Paragraph 1 -Article 5 falsefalse17false0natruenanaNo definition available.falsetruefalsefalsefalsefalsefalsefalsefalsefalsehttp://www.bms.com/taxonomy/role/disclosurebusinesssegmentinformationnetsalesofkeyproductsdetails1falsefal sefalse00falsefalsefalsefalsefalse2falsefalsefalse00falsefalsefalsefalsefalse3falsefalsefalse00falsefalsefalsefalsefalse4falsefalsefalse00falsefalsefalsefalsefalse5falsefalsefalse00falsefalsefalsefalsefalse6falsefalsefalse00falsefalsefalsefalsefalse7falsefalsefalse00falsefalsefalsefalsefalse8falsefalsefalse00falsefalsefalsefalsefalse9falsefalsefalse00falsefalsefalsefalsefalse10falsefalsefalse00falsefalsefalsefalsefalse11falsefalsefalse00falsefalsefalsefalsefalse33falsefalseUSDtruefalse{us-gaap_ConcentrationRiskByBenchmarkAxis} : Sales Revenue Segment Sprycel [Member] 1/1/2010 - 12/31/2010 USD ($) $Duration_1_1_2010_To_12_31_201022123http://www.sec.gov/CIK0000014272duration2010-01-01T00:00:002010-12-31T00:00:00falsefalseSales Revenue Segment Sprycel [Member]us-gaap_ConcentrationRiskByBenchmarkAxisxbrldihttp://xbrl.org/2006/xbrldibmy_SalesRevenueSegmentSprycelMemberus-gaap_ConcentrationRiskByBenchmarkAxisexplicitMemberUnit1Standardhttp://www .xbrl.org/2003/iso4217USDiso42170USDUSD$34falsefalseUSDtruefalse{us-gaap_ConcentrationRiskByBenchmarkAxis} : Sales Revenue Segment Sprycel [Member] 1/1/2009 - 12/31/2009 USD ($) $Duration_1_1_2009_To_12_31_200922108http://www.sec.gov/CIK0000014272duration2009-01-01T00:00:002009-12-31T00:00:00falsefalseSales Revenue Segment Sprycel [Member]us-gaap_ConcentrationRiskByBenchmarkAxisxbrldihttp://xbrl.org/2006/xbrldibmy_SalesRevenueSegmentSprycelMemberus-gaap_ConcentrationRiskByBenchmarkAxisexplicitMemberUnit1Standardhttp://www .xbrl.org/2003/iso4217USDiso42170USDUSD$35falsefalseUSDtruefalse{us-gaap_ConcentrationRiskByBenchmarkAxis} : Sales Revenue Segment Sprycel [Member] 1/1/2008 - 12/31/2008 USD ($) $Duration_1_1_2008_To_12_31_20083236http://www.sec.gov/CIK0000014272duration2008-01-01T00:00:002008-12-31T00:00:00falsefalseSales Revenue Segment Sprycel [Member]us-gaap_ConcentrationRiskByBenchmarkAxisxbrldihttp://xbrl.org/2006/xbrldibmy_SalesRevenueSegmentSprycelMemberus-gaap_ConcentrationRiskByBenchmarkAxisexplicitMemberUnit1Standardhttp://www. xbrl.org/2003/iso4217USDiso42170USDUSD$OthernaNo definition available.No authoritative reference available.falsefalse18false0us-gaap_SalesRevenueNetus-gaaptruecreditdurationNo definition available.falsefalsefalsefalsefalsefalsefalsefalsefalsefalseterselabel1falsefalsefalse00falsefalsefalsefalsefalse2falsefalsefalse00falsefalsefalsefalsefalse3falsefalsefalse00falsefalsefalsefalsefalse4falsefalsefalse00falsefalsefalsefalsefalse5falsefalsefalse00falsefalsefalse falsefalse6falsefalsefalse00falsefalsefalsefalsefalse7falsefalsefalse00falsefalsefalsefalse false8falsefalsefalse00falsefalsefalsefalsefalse9truefalsefalse576000000576falsefalsefalsef alsefalse10truefalsefalse421000000421falsefalsefalsefalsefalse11truefalsefalse310000000310falsefalsefalsefalsefalseMonetaryxbrli:monetaryItemTypemonetaryTotal revenue from sale of goods and services rendered during the reporting period, in the normal course of business, reduced by sales returns and allowances, and sales discounts.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Section 03 -Paragraph 1 -Article 5 falsefalse19false0natruenanaNo definition available.falsetruefalsefalsefalsefalsefalsefalsefalsefalsehttp://www.bms.com/taxonomy/role/disclosurebusinesssegmentinformationnetsalesofkeyproductsdetails1falsefal sefalse00falsefalsefalsefalsefalse2falsefalsefalse00falsefalsefalsefalsefalse3falsefalsefalse00falsefalsefalsefalsefalse4falsefalsefalse00falsefalsefalsefalsefalse5falsefalsefalse00falsefalsefalsefalsefalse6falsefalsefalse00falsefalsefalsefalsefalse7falsefalsefalse00falsefalsefalsefalsefalse8falsefalsefalse00falsefalsefalsefalsefalse9falsefalsefalse00falsefalsefalsefalsefalse10falsefalsefalse00falsefalsefalsefalsefalse11falsefalsefalse00falsefalsefalsefalsefalse36falsefalseUSDtruefalse{us-gaap_ConcentrationRiskByBenchmarkAxis} : Sales Revenue Segment Ixempra [Member] 1/1/2010 - 12/31/2010 USD ($) $Duration_1_1_2010_To_12_31_201022118http://www.sec.gov/CIK0000014272duration2010-01-01T00:00:002010-12-31T00:00:00falsefalseSales Revenue Segment Ixempra [Member]us-gaap_ConcentrationRiskByBenchmarkAxisxbrldihttp://xbrl.org/2006/xbrldibmy_SalesRevenueSegmentIxempraMemberus-gaap_ConcentrationRiskByBenchmarkAxisexplicitMemberUnit1Standardhttp://www .xbrl.org/2003/iso4217USDiso42170USDUSD$37falsefalseUSDtruefalse{us-gaap_ConcentrationRiskByBenchmarkAxis} : Sales Revenue Segment Ixempra [Member] 1/1/2009 - 12/31/2009 USD ($) $Duration_1_1_2009_To_12_31_200922102http://www.sec.gov/CIK0000014272duration2009-01-01T00:00:002009-12-31T00:00:00falsefalseSales Revenue Segment Ixempra [Member]us-gaap_ConcentrationRiskByBenchmarkAxisxbrldihttp://xbrl.org/2006/xbrldibmy_SalesRevenueSegmentIxempraMemberus-gaap_ConcentrationRiskByBenchmarkAxisexplicitMemberUnit1Standardhttp://www .xbrl.org/2003/iso4217USDiso42170USDUSD$38falsefalseUSDtruefalse{us-gaap_ConcentrationRiskByBenchmarkAxis} : Sales Revenue Segment Ixempra [Member] 1/1/2008 - 12/31/2008 USD ($) $Duration_1_1_2008_To_12_31_20083230http://www.sec.gov/CIK0000014272duration2008-01-01T00:00:002008-12-31T00:00:00falsefalseSales Revenue Segment Ixempra [Member]us-gaap_ConcentrationRiskByBenchmarkAxisxbrldihttp://xbrl.org/2006/xbrldibmy_SalesRevenueSegmentIxempraMemberus-gaap_ConcentrationRiskByBenchmarkAxisexplicitMemberUnit1Standardhttp://www. xbrl.org/2003/iso4217USDiso42170USDUSD$OthernaNo definition available.No authoritative reference available.falsefalse20false0us-gaap_SalesRevenueNetus-gaaptruecreditdurationNo definition available.falsefalsefalsefalsefalsefalsefalsefalsefalsefalseterselabel1falsefalsefalse00falsefalsefalsefalsefalse2falsefalsefalse00falsefalsefalsefalsefalse3falsefalsefalse00falsefalsefalsefalsefalse4falsefalsefalse00falsefalsefalsefalsefalse5falsefalsefalse00falsefalsefalse falsefalse6falsefalsefalse00falsefalsefalsefalsefalse7falsefalsefalse00falsefalsefalsefalse false8falsefalsefalse00falsefalsefalsefalsefalse9truefalsefalse117000000117falsefalsefalsef alsefalse10truefalsefalse109000000109falsefalsefalsefalsefalse11truefalsefalse101000000101falsefalsefalsefalsefalseMonetaryxbrli:monetaryItemTypemonetaryTotal revenue from sale of goods and services rendered during the reporting period, in the normal course of business, reduced by sales returns and allowances, and sales discounts.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Section 03 -Paragraph 1 -Article 5 falsefalse21false0natruenanaNo definition available.falsetruefalsefalsefalsefalsefalsefalsefalsefalsehttp://www.bms.com/taxonomy/role/disclosurebusinesssegmentinformationnetsalesofkeyproductsdetails1falsefal sefalse00falsefalsefalsefalsefalse2falsefalsefalse00falsefalsefalsefalsefalse3falsefalsefalse00falsefalsefalsefalsefalse4falsefalsefalse00falsefalsefalsefalsefalse5falsefalsefalse00falsefalsefalsefalsefalse6falsefalsefalse00falsefalsefalsefalsefalse7falsefalsefalse00falsefalsefalsefalsefalse8falsefalsefalse00falsefalsefalsefalsefalse9falsefalsefalse00falsefalsefalsefalsefalse10falsefalsefalse00falsefalsefalsefalsefalse11falsefalsefalse00falsefalsefalsefalsefalse39falsefalseUSDtruefalse{us-gaap_ConcentrationRiskByBenchmarkAxis} : Sales Revenue Segment Orencia [Member] 1/1/2010 - 12/31/2010 USD ($) $Duration_1_1_2010_To_12_31_201022120http://www.sec.gov/CIK0000014272duration2010-01-01T00:00:002010-12-31T00:00:00falsefalseSales Revenue Segment Orencia [Member]us-gaap_ConcentrationRiskByBenchmarkAxisxbrldihttp://xbrl.org/2006/xbrldibmy_SalesRevenueSegmentOrenciaMemberus-gaap_ConcentrationRiskByBenchmarkAxisexplicitMemberUnit1Standardhttp://www .xbrl.org/2003/iso4217USDiso42170USDUSD$40falsefalseUSDtruefalse{us-gaap_ConcentrationRiskByBenchmarkAxis} : Sales Revenue Segment Orencia [Member] 1/1/2009 - 12/31/2009 USD ($) $Duration_1_1_2009_To_12_31_200922105http://www.sec.gov/CIK0000014272duration2009-01-01T00:00:002009-12-31T00:00:00falsefalseSales Revenue Segment Orencia [Member]us-gaap_ConcentrationRiskByBenchmarkAxisxbrldihttp://xbrl.org/2006/xbrldibmy_SalesRevenueSegmentOrenciaMemberus-gaap_ConcentrationRiskByBenchmarkAxisexplicitMemberUnit1Standardhttp://www .xbrl.org/2003/iso4217USDiso42170USDUSD$41falsefalseUSDtruefalse{us-gaap_ConcentrationRiskByBenchmarkAxis} : Sales Revenue Segment Orencia [Member] 1/1/2008 - 12/31/2008 USD ($) $Duration_1_1_2008_To_12_31_20083233http://www.sec.gov/CIK0000014272duration2008-01-01T00:00:002008-12-31T00:00:00falsefalseSales Revenue Segment Orencia [Member]us-gaap_ConcentrationRiskByBenchmarkAxisxbrldihttp://xbrl.org/2006/xbrldibmy_SalesRevenueSegmentOrenciaMemberus-gaap_ConcentrationRiskByBenchmarkAxisexplicitMemberUnit1Standardhttp://www. xbrl.org/2003/iso4217USDiso42170USDUSD$OthernaNo definition available.No authoritative reference available.falsefalse22false0us-gaap_SalesRevenueNetus-gaaptruecreditdurationNo definition available.falsefalsefalsefalsefalsefalsefalsefalsefalsefalseterselabel1falsefalsefalse00falsefalsefalsefalsefalse2falsefalsefalse00falsefalsefalsefalsefalse3falsefalsefalse00falsefalsefalsefalsefalse4falsefalsefalse00falsefalsefalsefalsefalse5falsefalsefalse00falsefalsefalse falsefalse6falsefalsefalse00falsefalsefalsefalsefalse7falsefalsefalse00falsefalsefalsefalse false8falsefalsefalse00falsefalsefalsefalsefalse9truefalsefalse733000000733falsefalsefalsef alsefalse10truefalsefalse602000000602falsefalsefalsefalsefalse11truefalsefalse441000000441falsefalsefalsefalsefalseMonetaryxbrli:monetaryItemTypemonetaryTotal revenue from sale of goods and services rendered during the reporting period, in the normal course of business, reduced by sales returns and allowances, and sales discounts.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Section 03 -Paragraph 1 -Article 5 falsefalse23false0natruenanaNo definition available.falsetruefalsefalsefalsefalsefalsefalsefalsefalsehttp://www.bms.com/taxonomy/role/disclosurebusinesssegmentinformationnetsalesofkeyproductsdetails1falsefal sefalse00falsefalsefalsefalsefalse2falsefalsefalse00falsefalsefalsefalsefalse3falsefalsefalse00falsefalsefalsefalsefalse4falsefalsefalse00falsefalsefalsefalsefalse5falsefalsefalse00falsefalsefalsefalsefalse6falsefalsefalse00falsefalsefalsefalsefalse7falsefalsefalse00falsefalsefalsefalsefalse8falsefalsefalse00falsefalsefalsefalsefalse9falsefalsefalse00falsefalsefalsefalsefalse10falsefalsefalse00falsefalsefalsefalsefalse11falsefalsefalse00falsefalsefalsefalsefalse42falsefalseUSDtruefalse{us-gaap_ConcentrationRiskByBenchmarkAxis} : Sales Revenue Segment Onglyza/Kombiglyze [Member] 1/1/2010 - 12/31/2010 USD ($) $Duration_1_1_2010_To_12_31_201097http://www.sec.gov/CIK0000014272duration2010-01-01T00:00:002010-12-31T00:00:00falsefalseSales Revenue Segment Onglyza/Kombiglyze [Member]us-gaap_ConcentrationRiskByBenchmarkAxisxbrldihttp://xbrl.org/2006/xbrldibmy_SalesRevenueSegmentOnglyzaKombiglyzeMemberus-gaap_ConcentrationRiskByBenchmarkAxisexplicitMemberUnit1Standardhttp://www.xbrl.org/2003/iso4217USDiso42170USDUSD$43falsefalseUSDtruefalse{us-gaap_ConcentrationRiskByBenchmarkAxis} : Sales Revenue Segment Onglyza/Kombiglyze [Member] 1/1/2009 - 12/31/2009 USD ($) $Duration_1_1_2009_To_12_31_200922104http://www.sec.gov/CIK0000014272duration2009-01-01T00:00:002009-12-31T00:00:00falsefalseSales Revenue Segment Onglyza/Kombiglyze [Member]us-gaap_ConcentrationRiskByBenchmarkAxisxbrldihttp://xbrl.org/2006/xbrldibmy_SalesRevenueSegmentOnglyzaKombiglyzeMemberus-gaap_ConcentrationRiskByBenchmarkAxisexplicitMemberUnit1Standardhttp://www.xbrl.org/2003/iso4217USDiso42170USDUSD$44falsefalseUSDtruefalse{us-gaap_ConcentrationRiskByBenchmarkAxis} : Sales Revenue Segment Onglyza/Kombiglyze [Member] 1/1/2008 - 12/31/2008 USD ($) $Duration_1_1_2008_To_12_31_20083232http://www.sec.gov/CIK0000014272duration2008-01-01T00:00:002008-12-31T00:00:00falsefalseSales Revenue Segment Onglyza/Kombiglyze [Member]us-gaap_ConcentrationRiskByBenchmarkAxisxbrldihttp://xbrl.org/2006/xbrldibmy_SalesRevenueSegmentOnglyzaKombiglyzeMemberus-gaap_ConcentrationRiskByBenchmarkAxisexplicitMemberUnit1Standardhttp://www.xbrl.org/2003/iso4217USDiso42170USDUSD$OthernaNo definition available.No authoritative reference available.falsefalse24false0us-gaap_SalesRevenueNetus-gaaptruecreditdurationNo definition available.falsefalsefalsefalsefalsefalsefalsefalsefalsefalseterselabel1falsefalsefalse00falsefalsefalsefalsefalse2falsefalsefalse00falsefalsefalsefalsefalse3falsefalsefalse00falsefalsefalsefalsefalse4falsefalsefalse00falsefalsefalsefalsefalse5falsefalsefalse00falsefalsefalsefalsefalse6falsefalsefalse00falsefalsefalsefalsefalse7falsefalsefalse00falsefalsefals efalsefalse8falsefalsefalse00falsefalsefalsefalsefalse9truefalsefalse158000000158falsefalse falsefalsefalse10truefalsefalse2400000024falsefalsefalsefalsefalse11falsefalsefalse00&nbsp;falsefalsefalsefalsefalseMonetaryxbrli:monetaryItemTypemonetaryTotal revenue from sale of goods and services rendered during the reporting period, in the normal course of business, reduced by sales returns and allowances, and sales discounts.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Section 03 -Paragraph 1 -Article 5 falsefalse25false0natruenanaNo definition available.falsetruefalsefalsefalsefalsefalsefalsefalsefalsehttp://www.bms.com/taxonomy/role/disclosurebusinesssegmentinformationnetsalesofkeyproductsdetails1falsefal sefalse00falsefalsefalsefalsefalse2falsefalsefalse00falsefalsefalsefalsefalse3falsefalsefalse00falsefalsefalsefalsefalse4falsefalsefalse00falsefalsefalsefalsefalse5falsefalsefalse00falsefalsefalsefalsefalse6falsefalsefalse00falsefalsefalsefalsefalse7falsefalsefalse00falsefalsefalsefalsefalse8falsefalsefalse00falsefalsefalsefalsefalse9falsefalsefalse00falsefalsefalsefalsefalse10falsefalsefalse00falsefalsefalsefalsefalse11falsefalsefalse00falsefalsefalsefalsefalse45falsefalseUSDtruefalse{us-gaap_ConcentrationRiskByBenchmarkAxis} : Sales Revenue Segment Mature Products and All Other [Member] 1/1/2010 - 12/31/2010 USD ($) $Duration_1_1_2010_To_12_31_201022119http://www.sec.gov/CIK0000014272duration2010-01-01T00:00:002010-12-31T00:00:00falsefalseSales Revenue Segment Mature Products and All Other [Member]us-gaap_ConcentrationRiskByBenchmarkAxisxbrldihttp://xbrl.org/2006/xbrldibmy_SalesRevenueSegmentMatureProductsAndAllOtherMemberus-gaap_ConcentrationRiskByBenchmarkAxisexplicitMemberUnit1Standardhttp://www.xbrl.org/2003/iso4217USDiso42170USDUSD$46falsefalseUSDtruefalse{us-gaap_ConcentrationRiskByBenchmarkAxis} : Sales Revenue Segment Mature Products and All Other [Member] 1/1/2009 - 12/31/2009 USD ($) $Duration_1_1_2009_To_12_31_200922103http://www.sec.gov/CIK0000014272duration2009-01-01T00:00:002009-12-31T00:00:00falsefalseSales Revenue Segment Mature Products and All Other [Member]us-gaap_ConcentrationRiskByBenchmarkAxisxbrldihttp://xbrl.org/2006/xbrldibmy_SalesRevenueSegmentMatureProductsAndAllOtherMemberus-gaap_ConcentrationRiskByBenchmarkAxisexplicitMemberUnit1Standardhttp://www.xbrl.org/2003/iso4217USDiso42170USDUSD$47falsefalseUSDtruefalse{us-gaap_ConcentrationRiskByBenchmarkAxis} : Sales Revenue Segment Mature Products and All Other [Member] 1/1/2008 - 12/31/2008 USD ($) $Duration_1_1_2008_To_12_31_20083231http://www.sec.gov/CIK0000014272duration2008-01-01T00:00:002008-12-31T00:00:00falsefalseSales Revenue Segment Mature Products and All Other [Member]us-gaap_ConcentrationRiskByBenchmarkAxisxbrldihttp://xbrl.org/2006/xbrldibmy_SalesRevenueSegmentMatureProductsAndAllOtherMemberus-gaap_ConcentrationRiskByBenchmarkAxisexplicitMemberUnit1Standardhttp://www.xbrl.org/2003/iso4217USDiso42170USDUSD$OthernaNo definition available.No authoritative reference available.falsefalse26false0us-gaap_SalesRevenueNetus-gaaptruecreditdurationNo definition available.falsefalsefalsefalsefalsefalsefalsefalsefalsefalseterselabel1falsefalsefalse00falsefalsefalsefalsefalse2falsefalsefalse00falsefalsefalsefalsefalse3falsefalsefalse00falsefa lsefalsefalsefalse4falsefalsefalse00falsefalsefalsefalsefalse5falsefalsefalse00falsefalsefalsefalsefalse6falsefalsefalse00falsefalsefalsefalsefalse7falsefalsefalse00falsefalsefalsefalsefalse8falsefalsefalse00falsefalsefalsefalsefalse9truefalsefalse30530000003053falsetruefalsefalsefalse10truefalsefalse35360000003536falsetruefalsefalsefalse11truefalsefalse40860000004086falsetruefalsefalsefalseMonetaryxbrli:monetaryItemTypemonetaryTotal revenue from sale of goods and services rendered during the reporting period, in the normal course of business, reduced by sales returns and allowances, and sales discounts.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Section 03 -Paragraph 1 -Article 5 falsefalse1125BUSINESS SEGMENT INFORMATION (Net Sales of Key Products) (Details) (USD $)MillionsUnKnownUnKnownUnKnownfalsetrue